Engineering and physical sciences in oncology: challenges and opportunities.
about
Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.Compressive Force Spectroscopy: From Living Cells to Single Proteins.Immuno-Oncology: Emerging Targets and Combination TherapiesClinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patientsRadioactive (Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer
P2860
Q47707153-95F05D5D-3A8C-4ACC-9558-EA63742BEDD1Q50103495-626B8B8A-53AC-46C5-BA1A-B1EA2F6CA0F1Q52615294-5B5F1D70-F169-4FEC-B8D7-72795C9C7722Q53699572-2618168B-C117-41EF-8100-1DA2C7DD4B75Q54249880-2B3E4895-85C7-47C0-84A0-4D28C3C57FC3Q56889817-74A87ECC-6773-406F-A6DB-7401507C77E0Q57050576-EC161ADA-51FA-491F-9CBB-322B2939DD3CQ57377867-B3A4C6EC-0D73-493B-9A4A-A823903B6207
P2860
Engineering and physical sciences in oncology: challenges and opportunities.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Engineering and physical sciences in oncology: challenges and opportunities.
@en
Engineering and physical sciences in oncology: challenges and opportunities.
@nl
type
label
Engineering and physical sciences in oncology: challenges and opportunities.
@en
Engineering and physical sciences in oncology: challenges and opportunities.
@nl
prefLabel
Engineering and physical sciences in oncology: challenges and opportunities.
@en
Engineering and physical sciences in oncology: challenges and opportunities.
@nl
P2093
P2860
P356
P1476
Engineering and physical sciences in oncology: challenges and opportunities.
@en
P2093
Michael J Mitchell
Rakesh K Jain
Robert Langer
P2860
P2888
P304
P356
10.1038/NRC.2017.83
P407
P577
2017-10-13T00:00:00Z